Abstract
The bioavailability of RRR-α-tocopherol from the oral administration of RRR-α-tocopherol itself and its acetate and succinate esters was determined in healthy human subjects. Venous blood samples were withdrawn periodically over a 51-h period following oral administration of a gelatin capsule containing an equimolar mixture of RRR-α-tocopherol and RRR-α-tocopheryl acetate. In a second study, subjects received a capsule containing an equimolar mixture of RRR-α-tocopheryl acetate and RRR-α-tocopheryl succinate. In Study 1, RRR-α-tocopherol was absorbed at similar rates from both the free phenol, and the acetate ester and maximum plasma levels occurred at 12 h in most subjects. The extent of absorption of RRR-α-tocopherol varied considerably between subjects in absolute terms, but the relative absorption from the two forms was remarkably consistent, and a ratio of 1.0 was found for parameters of relative bioavailability in plasma. The concentration of RRR-α-tocopherol from each form was maximal at approximately 27 h in red blood cells and, as seen with the plasma data, there was a large inter-individual variability. In Study 2, there was no significant difference in the extent of absorption of RRR-α-tocopherol from the acetate ester and the succinate ester, although there was an apparently higher initial rate of absorption from the acetate ester.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.